Consolidated Balance Sheets (USD $) In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Current Assets
Cash and cash equivalents	$ 3,830.2	$ 4,018.8
Short-term investments	1,567.1	1,665.5
Accounts receivable, net of allowances of $100.3 (2013) and $108.5 (2012)	3,434.4	3,336.3
Other receivables	588.4	552.0
Inventories	2,928.8	2,643.8
Prepaid expenses and other	755.8	822.3
Total current assets	13,104.7	13,038.7
Other Assets
Investments	7,624.9	6,313.9
Goodwill and other intangibles, net	4,331.1	4,752.7
Sundry	2,212.5	2,533.4
Total other assets	14,168.5	13,600.0
Property and equipment, net	7,975.5	7,760.2
Total assets	35,248.7	34,398.9
Current Liabilities
Short-term borrowings and current maturies of long-term debt	1,012.6	11.9
Accounts payable	1,119.3	1,188.3
Employee compensation	943.9	940.3
Sales rebates and discounts	1,941.7	1,777.2
Dividends payable	523.5	541.4
Income taxes payable	254.4	143.5
Deferred income taxes	792.8	1,048.0
Other current liabilities	2,328.4	2,738.9
Total current liabilities	8,916.6	8,389.5
Other Liabilities
Long-term debt	4,200.3	5,519.4
Accrued retirement benefits	1,549.4	3,012.4
Long-term income taxes payable	1,078.7	1,334.3
Other noncurrent liabilities	1,863.0	1,369.4
Total other liabilities	8,691.4	11,235.5
Shareholders' Equity
Common stock	698.5	716.6
Additional paid-in capital	5,050.0	4,963.1
Retained earnings	16,992.4	16,088.2
Employee benefit trust	(3,013.2)	(3,013.2)
Accumulated other comprehensive loss	(2,002.7)	(3,797.1)
Cost of common stock in treasury	(93.6)	(192.4)
Total Eli Lilly and Company shareholders' equity	17,631.4	14,765.2
Noncontrolling interests	9.3	8.7
Total equity	17,640.7	14,773.9
Total liabilities and equity	$ 35,248.7	$ 34,398.9